Joel Schlessinger

Jul 17, 2024 | jamanetwork.com | Andrew Blauvelt |Emma Guttman-Yassky |Charles W. Lynde |Joel Schlessinger

Key PointsQuestion  Is cendakimab efficacious and safe in patients with moderate to severe atopic dermatitis (AD)? Findings  In this randomized clinical trial of 221 patients with moderate to severe AD, treatment with cendakimab was efficacious after 16 weeks, demonstrating improvements in skin clearance, pruritus, and the extent and severity of AD compared with placebo. Cendakimab was generally safe and well-tolerated.

Mar 1, 2024 | practicaldermatology.com | Joel Schlessinger

Each office and practitioner has their own approach to how they staff, and there is no right or wrong way. I started out with a ‘lean and mean’ mantra, and while I never thought I was particularly draconian, I have evolved my thinking significantly over the years. Since I have been in practice, my opinion on the size of my nursing and front desk teams has changed significantly.

Feb 8, 2024 | practicaldermatology.com | Gary Goldenberg |Joel Schlessinger |Porcia B. Love |Zoe Diana Draelos

Mark Birch-Machin, PhD Mark Birch-Machin, PhD, a professor of molecular dermatology at New Castle University, talks about the effects that air pollution can have on skin. Dr. Birch-Machin also talks about a recent study his team published in FASEB BioAdvances looking at the effects of air pollution on human skin equivalents, as well as what can be done to reverse damage caused by ozone. The study was supported by and conducted in collaboration with Kenvue.

Oct 14, 2023 | dermatologytimes.com | Emma Andrus |Joel Schlessinger

October 14, 2023Joel Schlessinger, MD, shares his atopic dermatitis insights. Throughout National Eczema Awareness Month, Dermatology Times® will be featuring Q&As with the expert dermatology professionals who are a part of our Editorial Advisory Board. Joel Schlessinger, MD, a board-certified dermatologist, board-certified Mohs surgeon and cosmetic surgeon in Omaha Nebraska, shares his insights into the evolving treatment and research landscapes of atopic dermatitis.

Oct 4, 2023 | practicaldermatology.com | Gary Goldenberg |Joel Schlessinger |Porcia B. Love |Zoe Diana Draelos

New York City-based dermatologist Ellen Gendler, MD, shares pearls from her recent talk at the 2023 annual meeting of the Menopause Society including the current thinking on how to address the effects of diminished estrogen on skin.